AB Vista continues to expand global market share
The company has seen tremendous growth in the Asia-Pacific region
Animal nutrition technology company AB Vista has achieved another year of growth in the global market share, driven largely by strong sales of the Quantum Blue and Econase XT enzyme product lines. In particular, the Asia-Pacific region saw sales more than 30% higher than the previous financial year.
According to Managing Director Richard Cooper, AB Vista has achieved positive results in the swine and poultry sectors in 2016. Cooper said, “Throughout the past year, we have significantly expanded our ruminant products and services portfolio, with new partnerships and team members in strategic markets putting in place a structure to grow in this market.”
2016 also marked the launch of a new global identity, defined as “Extraordinary Science Brought to Life.” Cooper said that the phrase sums up the company’s continued commitment to scientific innovation. “From AB Vista’s inception, we’ve sought to use science to develop new tools and technologies to meet industry challenges." He continued, “One such area today is phytate destruction – where we’ve worked with research partners to broaden our understanding of the effects of the anti-nutrient. As a result, the role of phytase superdosing in animal nutrition has been brought to the fore, with increased demand for products such as Quantum Blue.”
The company’s dedication to research was demonstrated at the recent International Phytate Summit (IPS3) in Florida, organized by AB Vista in conjunction with the University of Arkansas and the University of Illinois. The event brought together leading experts to collaborate on the current understanding of phytate and identify practical strategies to limit its anti-nutritive effect in feed.
Cooper said that the company will continue to lead the debate on the benefits of phytate destruction to build further success in 2017.